Company Avalanche Biotechnologies Inc Nasdaq
Equities
US05337G1076
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Gene Therapeutics
100.0
%
| 0 | nan % | 4 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 4 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 14/06/20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 11/12/22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/21 |
Romuald Corbau
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-28 |
Peter Soparkar
COO | Chief Operating Officer | 53 | 29/10/19 |
R. Ramelmeier
CTO | Chief Tech/Sci/R&D Officer | 62 | 20/08/23 |
Anand Reddi
HRO | Human Resources Officer | 42 | - |
Star Seyedkazemi
PRN | Corporate Officer/Principal | 50 | 05/01/22 |
Corporate Officer/Principal | - | 24/06/20 | |
Dena House
HRO | Human Resources Officer | - | 30/06/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Whitcup
BRD | Director/Board Member | 64 | 15/04/20 |
Clarence Machado
CHM | Chairman | 60 | 13/03/17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 14/06/20 |
Jim Scopa
BRD | Director/Board Member | 65 | 30/04/19 |
C. Nicholson
BRD | Director/Board Member | 68 | 11-02 |
Mark Lupher
BRD | Director/Board Member | 53 | 30/04/19 |
Reed Tuckson
BRD | Director/Board Member | 73 | 18/02/21 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 08/12/20 |
Rabia Ozden
BRD | Director/Board Member | 56 | 16/03/22 |
Soo Hong
BRD | Director/Board Member | 52 | 16/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,756,850 | 20,386,246 ( 98.21 %) | 0 | 98.21 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.67% | 12.27B |